Log in

Jazz Pharmaceuticals Earnings Date, Estimates & History (NASDAQ:JAZZ)

$134.82
-0.68 (-0.50 %)
(As of 02/23/2020 06:35 AM ET)
Today's Range
$133.38
Now: $134.82
$135.72
50-Day Range
$134.82
MA: $144.90
$152.74
52-Week Range
$116.52
Now: $134.82
$154.24
Volume435,258 shs
Average Volume425,100 shs
Market Capitalization$7.63 billion
P/E Ratio12.90
Dividend YieldN/A
Beta1.18

Earnings

Jazz Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, February 25th, 2020. Jazz Pharmaceuticals will be holding an earnings conference call on Tuesday, February 25th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Jazz Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Jazz Pharmaceuticals (NASDAQ:JAZZ) Earnings Estimates

Current Year EPS Consensus Estimate: $14.23 EPS
Next Year EPS Consensus Estimate: $16.02 EPS

Jazz Pharmaceuticals (NASDAQ JAZZ) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/25/2020
(Confirmed)
 $3.61    Register (After Market Closes)
11/5/2019Q3$3.19$4.10$5.52$523.92 million$537.70 millionTranscript
8/6/2019Q2$3.16$3.65$2.74$507.23 million$534.13 millionListen
5/7/20193/31/2019$2.83$3.27$5.07$466.55 million$508.19 millionTranscript
2/26/2019Q4 2018$2.66$3.27$3.90$459.48 million$476.46 millionListen
11/6/20189/30/2018$3.32$3.58$4.05$482.64 million$469.37 millionTranscript
8/7/20186/30/2018$3.23$3.49$4.72$469.85 million$500.48 millionN/A
5/8/20183/31/2018$2.78$2.98$4.51$435.69 million$444.61 millionN/A
2/27/2018Q4 2017$2.73$2.58$1.37$440.91 million$436.40 millionN/A
11/7/2017Q3 2017$2.53$2.93$4.83$420.67 million$411.86 millionN/A
8/8/20176/30/2017$1.85$1.72$1.72$410.83 million$394.39 millionListen
5/9/20173/31/2017$1.42$1.41$1.41$376.58 million$376.10 millionListen
2/28/2017Q416$2.65$1.91$1.91$398.91 million$396.62 millionListen
11/8/2016Q316$2.61$2.16$2.91$389.34 million$374.00 millionListen
8/9/2016Q216$2.80$2.63$1.80$376.40 million$381.00 millionN/A
5/10/2016Q1$2.31$2.26$2.55$338.86 million$336.00 millionListen
2/23/2016Q415$2.60$2.60$3.22$349.98 million$340.90 millionListen
11/9/2015Q315$2.56$2.52$1.39$348.15 million$340.90 millionListen
8/5/2015Q215$2.41$2.41$2.82$335.58 million$333.70 millionListen
5/7/2015Q115$2.15$1.99$2.18$309.50 million$309.30 millionListen
2/24/2015Q414$2.30$2.44$2.98$319.74 million$328.10 millionListen
11/4/2014Q314$1.98$2.33$3.79$302.90 million$306.58 millionListen
8/5/2014Q214$1.92$2.05$2.80$273.39 million$291.23 millionListen
5/8/2014Q114$1.79$1.61$4.34$254.86 million$247.00 millionListen
2/25/2014Q4 2013$1.65$1.52$2.14$238.12 million$235.80 millionListen
11/5/2013Q3 2013$1.52$1.66$2.09$227.38 million$232.20 millionListen
8/6/2013Q2 2013$1.37$1.26$1.83$208.71 million$208.30 millionListen
5/7/2013Q1 2013$1.18$1.24$1.77$189.92 million$196.20 millionListen
2/26/2013Q4 2012$1.41$1.53$183.80 million$183.70 millionListen
11/8/2012Q312$1.31$1.29$178.57 million$175.50 millionTranscript
8/7/2012$1.05$1.09N/A
5/8/2012$0.90$0.91N/A
2/27/2012Q4 2011$1.01$0.96$1.13N/A
11/1/2011$0.89$0.94N/A
7/28/2011$0.67$0.82N/A
5/3/2011$0.57$0.59N/A
3/7/2011$0.60$0.63Listen
11/4/2010Q3 2010$0.29$0.32$0.32N/A
8/10/2010Q2 2010$0.14$0.17$0.52N/A
5/5/2010Q1 2010$0.14$0.12$0.20N/A
3/3/2010Q4 2009$0.05$0.17$0.17N/A
11/5/2009Q3 2009($0.14)($0.05)($0.05)N/A
8/11/2009Q2 2009($0.33)$0.08$0.08N/A
5/7/2009Q1 2009($0.45)($0.45)N/A
3/26/2009Q4 2008($1.08)($0.97)$0.10N/A
11/13/2008Q3 2008($1.25)($1.07)($1.07)N/A
8/7/2008Q2 2008($1.74)($2.18)($2.18)N/A
5/13/2008Q1 2008($1.65)($1.97)($1.97)N/A
2/13/2008Q4 2007($1.87)($1.64)($0.75)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: What is a Call Option?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel